Skip to main content
Overview
Press Releases
Events
Financial Information
Quarterly Results
Annual Reports
SEC Filings
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Information Request Form
Investor Email Alerts
Investor Contacts
Skip to main content
Event Details
Overview
Press Releases
Events
Financial Information
Quarterly Results
Annual Reports
SEC Filings
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Information Request Form
Investor Email Alerts
Investor Contacts
ESMO 2020 Presentation of Single-agent Anti-PD-1 Balstilimab or in Combination with Anti-CTLA-4 Zalifrelimab for Recurrent/Metastatic (R/M) Cervical Cancer (CC)
September 18, 2020 9:00 AM CEST
Webcast
(opens in new window)